QT
AQST icon

Quantbot Technologies’s Aquestive Therapeutics AQST Stock Holding History

Quantbot Technologies’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$429K Buy
103,446
+84,985
+460% +$345K 0.02% 911
2025
Q4 		$119K Sell
18,461
-14,746
-44% -$91.9K ﹤0.01% 1379
2025
Q3 		$186K Buy
+33,207
New +$144K 0.01% 1317
2025
Q2 		– Sell
-851
Closed -$2.47K – 1616
2025
Q1 		$2.47K Buy
+851
New +$2.58K ﹤0.01% 1400
2024
Q4 		– Sell
-27,198
Closed -$135K – 1455
2024
Q3 		$135K Buy
+27,198
New +$106K 0.01% 1114
2024
Q2 		– Sell
-8,200
Closed -$34.9K – 1417
2024
Q1 		$34.9K Buy
+8,200
New +$27.3K ﹤0.01% 1370
2022
Q4 		– Sell
-3,751
Closed -$4K – 1656
2022
Q3 		$4K Hold
3,751
– – ﹤0.01% 1481
2022
Q2 		$2K Hold
3,751
– – ﹤0.01% 1622
2022
Q1 		$9K Buy
+3,751
New +$11K ﹤0.01% 1472
2021
Q4 		– Sell
-1,400
Closed -$6K – 1478
2021
Q3 		$6K Buy
+1,400
New +$5.49K ﹤0.01% 1393
2021
Q1 		– Sell
-2,783
Closed -$14K – 1389
2020
Q4 		$14K Buy
+2,783
New +$16.7K ﹤0.01% 1060

Other funds holding AQST

BCM
Bratton Capital Management Fort Worth, Texas $40.7M AUM 43.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Quantbot Technologies's AQST Position: Q1 2026 in Review

Quantbot Technologies increased its Aquestive Therapeutics (AQST) stake by 460% in Q1 2026, buying an estimated $345K and bringing the position to 103,446 shares worth $429K. The position accounts for 0.02% of the portfolio, ranked #911.

Quantbot Technologies first reported a position in AQST in Q4 2020 and has held it in 11 quarters since. 179 funds tracked by Wall St. Rank hold AQST as of Q1 2026.

  • Quantbot Technologies held 103,446 shares of Aquestive Therapeutics worth $429K as of Q1 2026.
  • Quantbot Technologies bought 84,985 Aquestive Therapeutics shares in Q1 2026, an estimated $345K.
  • Aquestive Therapeutics made up 0.02% of Quantbot Technologies's portfolio in Q1 2026, its #911 holding.
  • Quantbot Technologies first reported a position in Aquestive Therapeutics in Q4 2020 and has held it in 11 quarters since.
  • 179 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q1 2026.

Based on Quantbot Technologies's 13F filing for Q1 2026, filed 13 May 2026.